Treatment of special populations with chronic hepatitis B infection

Autor: Stephanos J. Hadziyannis, Irene Rapti

Publikováno v: Expert Review of Gastroenterology & Hepatology. 5:323-339

All therapeutic agents that are currently in use for the treatment of chronic hepatitis B have been administered to a large number of patients in clinical trials in order to be approved as efficacious and safe. Nevertheless, in these trials, many pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef028360ac138b1c35b958ea3cda46b5
https://doi.org/10.1586/egh.11.7

Aetiology and outcome of acute hepatic failure in Greece: experience of two academic hospital centres

Autor: John, Koskinas, Melanie, Deutsch, Dimitris, Kountouras, Georgia, Kostopanagiotou, Nikos, Arkadopoulos, Vasilis, Smyrniotis, Irene, Rapti, Emmanuel, Manesis, Athanasios, Archimandritis

Publikováno v: Liver international : official journal of the International Association for the Study of the Liver. 28(6)

Introduction: In Western countries, the most frequent aetiology of acute liver failure (ALF) is acetaminophen overdose, while in developing countries viral infections [hepatitis A virus and hepatitis B virus (HBV)] predominate. Aim: To evaluate the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::85c60a572b99c501e8b63871831ff287
https://pubmed.ncbi.nlm.nih.gov/18492016

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine

Autor: Spilios Manolakopoulos, Stephanos J. Hadziyannis, Irene Rapti, Emanuel K. Manesis, Dimitrios Tzourmakliotis, George V. Papatheodoridis, Konstantinos Dimakopoulos, Evangelini Dimou, George Kitis

Publikováno v: Hepatology (Baltimore, Md.). 42(1)

We determined the clinical outcome of hepatitis e antigen (HBeAg)-negative chronic hepatitis B patients treated with long-term nucleos(t)ide analog therapy starting with lamivudine. We evaluated 201 such patients treated for 3.8 +/- 1.4 years and 2 h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029009f22449dc5dd97640e800bd744f
https://pubmed.ncbi.nlm.nih.gov/15962291

Erratum to 'Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B'

Autor: Ruggero Panebianco, S. Cerioni, Julian Jenkins, Vincenzo Lamonaca, Amalia Penna, Carolina Boni, A. Cavalli, Massimo Pilli, Simona Urbani, Gabriele Missale, Antonio Bertoletti, Carlo Ferrari, Irene Rapti

Publikováno v: Journal of Hepatology. 40:1053-1054

Erratum to “Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B” [J Hepatol 39 (2003) 595–605] Carolina Boni, Amalia Penna, Antonio Bertoletti, Vincenzo Lamonaca, Irene Rapti, Gabriele Missa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34a17e672c95c329415ba6e635d6b7f8
https://doi.org/10.1016/j.jhep.2004.04.011

Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues.

Autor: Rapti I; Irene Rapti, Stephanos Hadziyannis, Liver Unit and its Molecular Biology Laboratory, National and Kapodistrian University of Athens, Evgenidion Hospital of Athens, 15669 Athens, Greece., Hadziyannis S; Irene Rapti, Stephanos Hadziyannis, Liver Unit and its Molecular Biology Laboratory, National and Kapodistrian University of Athens, Evgenidion Hospital of Athens, 15669 Athens, Greece.

Publikováno v: World journal of hepatology [World J Hepatol] 2015 May 18; Vol. 7 (8), pp. 1064-73.